Total amount raised
$110 Millions
Latest funding date
Location
Artera has successfully raised funding through multiple rounds, with notable investors including Trium Limited and Andrew Tan. The company specializes in developing multimodal AI-based predictive and prognostic cancer tests to customize treatments for cancer patients.
Artera's platform leverages digital pathology images and clinical data to provide individualized treatment recommendations, particularly for prostate cancer. Keep reading to explore the intricacies of Artera's fundraising journey and the investors backing this innovative platform.
What Is Artera?
Artera, founded in 2021 by Andre Esteva and Felix Feng, is based in Los Altos, California. The company specializes in developing multimodal AI-based predictive and prognostic cancer tests to customize treatments for cancer patients. With a team of 101-250 employees, Artera focuses on providing personalized therapy, particularly for prostate cancer, through its innovative AI platform.
How Much Funding Has Artera Raised?
- Amount Raised: $90M
- Date: March 2023
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The company aimed to emerge from stealth mode and support its initial growth phase.
- Amount Raised: $20M
- Date: February 2024
- Lead Investors: Prosperity7 Ventures, EDBI, Walden Catalyst Ventures, Wilson Sonsini Goodrich & Rosati, Trium Ventures, Navin Chaddha, Rajiv Khemani, Andrew & Elliott Tan
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funding will support international expansion and commercial growth, furthering the mission to personalize cancer therapy through AI-enabled predictive and prognostic tests.
Total Amount Raised: $110M. Current Valuation: Not publicly disclosed.
Key Investors
- Prosperity7 Ventures
- Details: Prosperity7 Ventures is the diversified growth fund of Aramco Ventures, a subsidiary of Aramco. They focus on breakthrough technologies and transformational business models.
- Investment Focus Areas: Breakthrough technologies, transformational business models.
- Notable Investments: Not publicly disclosed.
- EDBI
- Details: EDBI is a Singapore-based global investor in high-growth technologies. They support companies expanding into Asia.
- Investment Focus Areas: Information & Communication Technology, Emerging Technology, Healthcare.
- Notable Investments: Not publicly disclosed.
- Walden Catalyst Ventures
- Details: Walden Catalyst Ventures is a venture capital firm. Specific details about the firm were not provided in the sources.
- Investment Focus Areas: Not publicly disclosed.
- Notable Investments: Not publicly disclosed.
- Wilson Sonsini Goodrich & Rosati
- Details: Wilson Sonsini Goodrich & Rosati is a law firm. Specific details about the firm were not provided in the sources.
- Investment Focus Areas: Not publicly disclosed.
- Notable Investments: Not publicly disclosed.
- Trium Ventures
- Details: Trium Ventures is a venture capital firm. Specific details about the firm were not provided in the sources.
- Investment Focus Areas: Not publicly disclosed.
- Notable Investments: Not publicly disclosed.
What's Next for Artera?
Artera stands on the brink of significant international expansion, driven by its recent $20 million funding. This opportunity could open doors to new markets and partnerships, enhancing the reach of its AI-enabled cancer tests. The potential for growth is substantial, given the increasing adoption of AI in precision medicine and the company's established success in securing Medicare payment rates for its prostate test.
Future fundraising appears promising as Artera continues to attract investment to support its ambitious growth plans. However, the company may face challenges such as navigating regulatory approvals in different countries and ensuring the scalability of its AI algorithms. Competition in the AI healthcare sector also remains a significant hurdle.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Artera and gather other critical business insights. Sign up for free and start leveraging these powerful tools today.
